Cargando…
NAD(+) in Alzheimer’s Disease: Molecular Mechanisms and Systematic Therapeutic Evidence Obtained in vivo
Mitochondria in neurons generate adenosine triphosphate (ATP) to provide the necessary energy required for constant activity. Nicotinamide adenine dinucleotide (NAD(+)) is a vital intermediate metabolite involved in cellular bioenergetics, ATP production, mitochondrial homeostasis, and adaptive stre...
Autores principales: | Wang, Xinshi, He, Hai-Jun, Xiong, Xi, Zhou, Shuoting, Wang, Wen-Wen, Feng, Liang, Han, Ruiyu, Xie, Cheng-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369418/ https://www.ncbi.nlm.nih.gov/pubmed/34414179 http://dx.doi.org/10.3389/fcell.2021.668491 |
Ejemplares similares
-
Alzheimer’s disease: Pathophysiology and dental pulp stem cells therapeutic prospects
por: Xiong, Wei, et al.
Publicado: (2022) -
Circulating NAD+ Metabolism-Derived Genes Unveils Prognostic and Peripheral Immune Infiltration in Amyotrophic Lateral Sclerosis
por: Li, Cheng, et al.
Publicado: (2022) -
Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism
por: Hong, Weiqi, et al.
Publicado: (2020) -
High-Throughput Metabolomics for Discovering Potential Biomarkers and Identifying Metabolic Mechanisms in Aging and Alzheimer’s Disease
por: Xie, Kun, et al.
Publicado: (2021) -
Ferroptosis, a Potential Therapeutic Target in Alzheimer’s Disease
por: Chen, Kai, et al.
Publicado: (2021)